Benzinga | Nov 8, 2021 09:57AM EST

Earnings Outlook For Acorda Therapeutics

Acorda Therapeutics (NASDAQ:ACOR) is set to give its latest quarterly earnings report on Tuesday, 2021-11-09. Here's what investors need to know before the announcement.

Analysts estimate that Acorda Therapeutics will likely report an Earnings Per Share (EPS) of $-1.56

Acorda Therapeutics bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed on EPS by -10.53%, which was followed by a 10.98% drop in the share price the next day.

Here's a look at Acorda Therapeutics's past performance and the resulting price change:

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020EPS Estimate -2.09 -2.54 -1.48 -0.31EPS Actual -1.87 -2.46 -2.50 -0.23Price Change % -10.98% -2.34% -23.01% -15.0%

Stock Performance

Shares of Acorda Therapeutics were trading at $3.88 as of November 04. Over the last 52-week period, shares are down nan%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

If you want to track all upcoming earnings announcements, check out our Earnings Calendar here